Skip to main content
Caplight Logo









Retromer Therapeutics

Retromer Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://cinrx.com

Company Overview

Retromer Therapeutics is a biotechnology company that develops disease-modifying therapeutics for neurodegenerative diseases by enhancing endolysosomal transport and stabilizing the retromer pathway.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryneurodegenerative diseasesmall molecule therapeuticsgene therapyretromer complexpharmacologic chaperonesendolysosomal functionpreclinical researchbiotech startupdrug developmenttherapeutic assetsneurosciencelife sciencesdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Retromer Therapeutics Comparables

Compare Retromer Therapeutics with similar companies based on industry and business-model similarity.

Retromer Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arkuda Therapeutics
83%
Cantabio Pharmaceuticals
82%
Endlyz Therapeutics
81%
View all Comparables

Retromer Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Retromer Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Retromer Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Retromer Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?